12/19
05:00 pm
ango
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
Medium
Report
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
12/10
01:09 pm
ango
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife [Yahoo! Finance]
Neutral
Report
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife [Yahoo! Finance]
12/10
12:50 pm
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
12/10
11:08 am
ango
Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength? [Yahoo! Finance]
12/9
01:24 pm
ango
NanoKnife gains FDA clearance for prostate tissue ablation [Yahoo! Finance]
Low
Report
NanoKnife gains FDA clearance for prostate tissue ablation [Yahoo! Finance]
12/9
06:03 am
ango
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation [Yahoo! Finance]
Low
Report
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation [Yahoo! Finance]
12/9
06:00 am
ango
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
High
Report
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
12/3
01:08 pm
ango
NARI Stock Likely to Gain Following Reimbursement Approval in Japan [Yahoo! Finance]
Low
Report
NARI Stock Likely to Gain Following Reimbursement Approval in Japan [Yahoo! Finance]
11/29
04:17 am
ango
Vascular Access Devices Market Insights, Competitive Landscape and Market Forecasts to 2030 [Yahoo! Finance]
Low
Report
Vascular Access Devices Market Insights, Competitive Landscape and Market Forecasts to 2030 [Yahoo! Finance]
11/28
12:33 pm
ango
MDT Stock May Gain Following the Positive Data From Optimize PRO Study [Yahoo! Finance]
Low
Report
MDT Stock May Gain Following the Positive Data From Optimize PRO Study [Yahoo! Finance]
11/22
12:49 pm
ango
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System [Yahoo! Finance]
Neutral
Report
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System [Yahoo! Finance]
11/21
10:53 am
ango
Photomedicine Devices and Technologies (Dermatology, Wound Healing Pain Management, Optical Diagnostics, Oncology) Market Size, Share and Trends Analysis Report 2024-2030 [Yahoo! Finance]
Low
Report
Photomedicine Devices and Technologies (Dermatology, Wound Healing Pain Management, Optical Diagnostics, Oncology) Market Size, Share and Trends Analysis Report 2024-2030 [Yahoo! Finance]
11/18
12:34 pm
ango
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study [Yahoo! Finance]
Low
Report
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study [Yahoo! Finance]
11/15
09:53 am
ango
SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments [Yahoo! Finance]
Low
Report
SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments [Yahoo! Finance]
11/15
09:53 am
ango
SYK Stock Rises Following the Launch of Next Generation SurgiCount+ [Yahoo! Finance]
Low
Report
SYK Stock Rises Following the Launch of Next Generation SurgiCount+ [Yahoo! Finance]
11/11
11:49 am
ango
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape [Yahoo! Finance]
Low
Report
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape [Yahoo! Finance]
10/24
08:21 am
ango
AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
Low
Report
AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
10/23
02:15 pm
ango
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
Low
Report
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
10/23
08:00 am
ango
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
Medium
Report
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
10/22
10:56 am
ango
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
Medium
Report
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
10/21
08:00 am
ango
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
Medium
Report
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
10/4
01:35 pm
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
10/4
11:36 am
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $12.00. They now have a "buy" rating on the stock.